Recherche Med.Uni-muenchen.de.2Cannabinoid et le groupe de traitement, département de psychiatrie et psychothérapie, hôpital universitaire, LMU Munich, Nußbaumstr. 7, 80336, Munich, Germany.3APOPO, Université de l’Agriculture, Université Martin-Luther, Morogoro, Tanzania.4Vitos hôpital psychiatrie et psychothérapie, département de psychiatrie, psychothérapie et psychosomatique, Université Martin-Luther, Halle-Wittenberg, inCorrection Germany.Erratum à :
View the Original article
Articles similaires
+32 471/520 460
Comment efficace et sécuritaire est cannabis médical comme traitement des troubles mentaux ? Un examen systématique.
Published by Michael on
Recherche Med.Uni-muenchen.de.2Cannabinoid et le groupe de traitement, département de psychiatrie et psychothérapie, hôpital universitaire, LMU Munich, Nußbaumstr. 7, 80336, Munich, Germany.3APOPO, Université de l’Agriculture, Université Martin-Luther, Morogoro, Tanzania.4Vitos hôpital psychiatrie et psychothérapie, département de psychiatrie, psychothérapie et psychosomatique, Université Martin-Luther, Halle-Wittenberg, inCorrection Germany.Erratum à :
View the Original article
Share this:
Articles similaires
Related Posts
Medical
Morbidity and mortality in schizophrenia with comorbid substance use disorders
Acta Psychiatr Scand. 2021 Mar 1. doi: 10.1111/acps.13291. Online ahead of print. ABSTRACT OBJECTIVE: Schizophrenia is highly comorbid with substance use disorders (SUD) but large epidemiological cohorts exploring the prevalence and prognostic significance of SUD Read more…
Medical
A Digital Health Tool to Understand and Prevent Cannabis-Impaired Driving Among Youth: A Cross-sectional Study of Responses to a Brief Intervention for Cannabis Use
JMIR Form Res. 2021 Mar 2;5(3):e25583. doi: 10.2196/25583. ABSTRACT BACKGROUND: Cannabis legalization has raised concern about an increased risk of cannabis-impaired driving, particularly among youth. Youth advocates and policy makers require cost-effective tools to target Read more…
Medical
The Impact of Depressed Mood and Coping Motives on Cannabis Use Quantity across the Menstrual Cycle in those with and without Pre-Menstrual Dysphoric Disorder
Addiction. 2021 Mar 2. doi: 10.1111/add.15465. Online ahead of print. ABSTRACT BACKGROUND AND AIMS: Reported rates of cannabis use among Canadian females are increasing. Female cannabis users progress to cannabis use disorder more rapidly than Read more…